Retractable Technologies Inc (RVP)
0.7102
-0.01
(-1.59%)
USD |
NYAM |
Nov 01, 16:00
0.7005
-0.01
(-1.37%)
After-Hours: 20:00
Retractable Technologies Enterprise Value: -19.02M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | -19.02M |
| October 31, 2024 | -18.68M |
| October 30, 2024 | -18.91M |
| October 29, 2024 | -18.26M |
| October 28, 2024 | -18.13M |
| October 25, 2024 | -18.33M |
| October 24, 2024 | -18.43M |
| October 23, 2024 | -18.13M |
| October 22, 2024 | -17.54M |
| October 21, 2024 | -17.46M |
| October 18, 2024 | -17.53M |
| October 17, 2024 | -17.47M |
| October 16, 2024 | -16.66M |
| October 15, 2024 | -16.96M |
| October 14, 2024 | -17.57M |
| October 11, 2024 | -17.57M |
| October 10, 2024 | -17.68M |
| October 09, 2024 | -17.16M |
| October 08, 2024 | -17.17M |
| October 07, 2024 | -17.38M |
| October 04, 2024 | -17.80M |
| October 03, 2024 | -17.98M |
| October 02, 2024 | -17.24M |
| October 01, 2024 | -17.37M |
| September 30, 2024 | -17.23M |
| Date | Value |
|---|---|
| September 27, 2024 | -17.59M |
| September 26, 2024 | -18.70M |
| September 25, 2024 | -18.58M |
| September 24, 2024 | -17.83M |
| September 23, 2024 | -18.73M |
| September 20, 2024 | -16.96M |
| September 19, 2024 | -13.38M |
| September 18, 2024 | -13.63M |
| September 17, 2024 | -13.42M |
| September 16, 2024 | -13.34M |
| September 13, 2024 | -13.04M |
| September 12, 2024 | -13.16M |
| September 11, 2024 | -13.21M |
| September 10, 2024 | -13.30M |
| September 09, 2024 | -12.80M |
| September 06, 2024 | -12.45M |
| September 05, 2024 | -12.92M |
| September 04, 2024 | -12.59M |
| September 03, 2024 | -12.74M |
| August 30, 2024 | -12.29M |
| August 29, 2024 | -12.14M |
| August 28, 2024 | -12.35M |
| August 27, 2024 | -11.84M |
| August 26, 2024 | -11.85M |
| August 23, 2024 | -11.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-19.02M
Minimum
Nov 01 2024
708.44M
Maximum
Feb 01 2021
121.56M
Average
42.64M
Median
Jan 16 2020
Enterprise Value Benchmarks
| Plus Therapeutics Inc | 2.817M |
| Perspective Therapeutics Inc | 524.04M |
| InfuSystems Holdings Inc | 170.22M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.16M |
| Revenue (Quarterly) | 6.029M |
| Total Expenses (Quarterly) | 10.32M |
| EPS Diluted (Quarterly) | -0.48 |
| Gross Profit Margin (Quarterly) | -6.96% |
| Profit Margin (Quarterly) | -234.9% |
| Earnings Yield | -85.89% |
| Normalized Earnings Yield | -65.37 |